Exhibit info
We look forward to welcoming you to our booth and talk with you about our solutions for an integrated Personalised Diabetes Management!
For those who will join the ATTD conference online, please make sure to visit our virtual Showroom, where you find more information on integrated Personalised Diabetes Management. Feel free to contact us for more information and visit us on LinkedIn .
Location
Fortezza de Basso
Viale Filippo Strozzi, 1
50129 Florence, Italy
and online
Exhibition
Exhibition Hall “Padiglione Spadolini”, booth no. 7
Opening hours
Wednesday, March 6: 18:30 – 20:00 (Opening Ceremony)
Thursday, March 7: 9:30 – 17:00
Friday, March 8: 10:00 – 17:30
Saturday, March 9: 10:30 – 12:00
Receive Roche Diabetes Care solutions brochures and publications links via email!
Order now
Publications
Automated Bolus Advisor
Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes - The BolusCal Study, a randomized controlled pilot study
(Schmidt et al. Diabetes Care, 2012 May;35(5):984-90.)
Read publication
Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial
(Ziegler et al. Diabetes Care. 2013 Nov; 36(11):3613-9.)
Read publication
SMBG – System Performance
System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose According to DIN EN ISO 15197
(Freckmann et al. J Diabetes Sci Technol. 2012 Sep 1;6(5):1060-75.)
Read publication
System accuracy evaluation of 18 CE marked current generation blood glucose monitoring systems based on EN ISO 15197:2015
(Pleus et al. BMJ Open Diabetes Res Care. 2020, 8(1): e001067)
Read publication
Structured Testing and Pattern Analysis
Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study
(Mora et al. Diabetes Technol Ther. 2017 Dec 1;19(12):715-22.)
Read publication
Evaluation of a new digital automated glycemic pattern detection tool
(Comellas et al. Diabetes Techno Ther. 2017 Nov 1;19(11):633-40)
Read publication
Use of Diabetes Data Management Software Reports by Health Care Providers, Patients With Diabetes, and Caregivers Improves Accuracy and Efficiency of Data Analysis and Interpretation Compared With Traditional Logbook Data: First Results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES)
(Hinnen et al. J Diabetes Sci Technol. 2015 Mar:9(2):293-301.)
Read publication
What Do We Need beyond Hemoglobin A1c to Get the Complete Picture of glycemia in people with diabetes?
(Hinzmann et al. Int. J Med Sci. 2012;9(8):665-81.)
Read publication
CGM
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II
(Christiansen et al. Diabetes Technol. Ther. 2018 Jan 30 (Epub))
Read publication
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial
(Kropff et al. Diabetes Care 2017 Jan:40(1):63-68.)
Read publication
Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
(Heinemann et al. J Diabetes Sci Technol. 2019 Jun (Epub))
Read publication
Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice
(Johnson et al. J Diabetes Sci Technol. 2019 Jun:21(S2):S217-5225.)
Read publication
Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
(Heinemann et al. J Diabetes Sci Technol. 2020 Jan;14(1):135–150.)
Read publication
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
(Ziegler et al. J Diabetes Sci Technol. 2021 May;15(3):684-694.)
Read publication
Standardization process of continuous glucose monitoring: Traceability and performance
(Freckmann et al. Clin. Chim. Acta. 2021 Apr;515:5-12.)
Read publication
CSII
Boluses in insulin therapy: A Commentary
(Ziegler et al. J Diabetes Technol. 2017;11(1):165-71.)
Read publication
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
(Steineck et al. BMJ 2015; 350: h3234.)
Read publication
Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?
(Barnard et al. J Diabetes Sci Technol. 2018 Nov;12(6):1223-1226)
Read publication
Patch Pumps: Are They All the Same?
(Heinemann et al. J Diabetes Sci Technol. 2019 Jan:13(1):34-40.)
Read publication
Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps
(Kamecke et al. J Diabetes Sci Technol. 2018; ePub)
Read publication
Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates
(Freckmann et al. J Diabetes Sci Technol. 2018;12(3):608-613)
Read publication
Continuous subcutaneous insulin infusion: Special needs for children
(Adolfsson et al. Pediatr. Diabetes 2017 Jan;18(4):225-261.)
Read publication
Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction
(Deeb et al. Clin. Diabetes Endocrinol. 2019 Jun 6;5:7.)
Read publication
Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
(Freckmann et al. Diabetes Technol. Ther. 2019 Apr;21(4):201-208)
Read publication
Comparative Handling Analysis of Different Insulin Pump Systems
(Waldenmaier et al. J Diabetes Sci Technol. 2018 Mar;12(2):401-406)
Read publication
Concept and Implementation of a Novel Patch Pump for Insulin Delivery
(Ulbrich et al. J Diabetes Sci Technol. 2019 Aug (Epub))
Read publication
Concept and Implementation of a Novel Patch Pump for Insulin Delivery
(Ulbrich et al. J Diabetes Sci Technol. 2020 Mar;14(2):324-327.)
Read publication
Analysis of the Waste Volume and CO 2-Equivalent Caused by the Use of Selected Patch Pumps
(Winkelkötter et al. J Diabetes Sci Technol. 2021 (Epub))
Read publication
Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies
(Freckmann et al. J Diabetes Sci Technol. 2020 (Epub))
Read publication
Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents
(Ziegler et al. Pediatr. Diabetes. 2020 Jun;21(4):649-656.)
Read publication
Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
(Ziegler et al. Diabetes Technol. Ther. 2021 May;23(5):350-357.)
Read publication
Digital Solutions
Utilizing eHealth and Telemedicine Technologies to Enhance Access and Quality
(Barnard et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)
Read publication
A Digital-First Model of Diabetes Care
(Cafazzo et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821))
Read publication
Real-World Assessments of mySugr Mobile Health App
(Debong et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)
Read publication
Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy
(Forlenza et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)
Read publication
The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care
(Garg et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)
Read publication
Current Status and Future Directions for Electronic Point-of-Care Clinical Decision Support to Improve Diabetes Management in Primary Care
(O'Connor et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)
Read publication
Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings - Lessons Learned from Emerging Economies
(Pradeepa et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821)
Read publication
Virtual Coaching to Enhance Diabetes Care
(Ramchandani et al. J Diabetes Sci Technol. 2017 Jul;11(4):814-821.)
Read publication
Integrated Personalised Diabetes Management
Benefit of Digital Tools Used for Intergrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program
(Heinemann et al. J Diabetes Sci Technol. 2019 Aug (Epub))
Read publication
Patient-centred care in type 2 diabetes mellitus - key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report
(Fritzen et al. Diabetes Res. Clin. Pract. 2019 Dec (Epub))
Read publication
Intergrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program
(Kulzer et al. Diab. Res. Clin. Pract. 2018 Oct;144:200-2012)
Read publication
Intergrated Personalized Diabetes Management (PDM): Design of the ProValues Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.
(Kulzer et al. J Diabetes Sci Technol. 2016 May;10(3):722-781.)
Read publication
PDM-ProValue meets cardiovascular outcome trials in diabetes
(Fritzen et al. Cardiovasc. Diabetol. 2019 Jan 28;18(1):10)
Read publication
Chronic Kidney Disease
Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
(Ravizza et al. Nat Med. 2019 Jan:25(1):57-59.)
Read publication
Other
Modeling of Diabetes and Its Clinical Impact
(Fritzen et al. Diabetes Sci Technol. 2018 Sep;12(5):976-984.)
Read publication
Diabetes management intervention studies: lessons learned from two studies
(Petersen et al. Trials, 2021 Jan 18;22(1):61.)
Read publication
CIPII
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes
(Pasquini et al. Acta Diabetol. 2019 Aug 9.)
Read publication
A New Optimized Percutaneous Access System for CIPII
(Garcia-Verdugo et al. J Diabetes Sci Technol. 2019 Jul;11(4):814-821)
Read publication
Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study
(Dassau et al. Diabetes Obs. Metab. 2017 Dec;19(12):1698-1705.)
Read publication
New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion
(Rieger et al. J Diabetes Sci Technol. 2019 Jun (Epub))
Read publication
Automated Insulin Delivery
Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes
(Brown et al. Clin. Endocrinol. Metab. 2017 Oct 1;102(10):3674-3682.)
Read publication
Twelve-week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin a1c and Hypoglycemia
(Dassau et al. Diabetes Care 2018 Dec;40(12):1719-1726.)
Read publication
Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study
(Breton et al. Diabetes Care 2017 Dec;40(12):1644-1650.)
Read publication
Closed-Loop Control Without Meal Announcement in Type 1 Diabetes
(Cameron et al. Diabetes Technol. Ther. 2017 Sep;19(9):527-532.)
Read publication
Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses
(Sanchez-Pena et al. J Diabetes Sci Technol. 2018 Sep;12(5):914-925.)
Read publication
Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp.
(Ly et al. Diabetes Care 2016 Aug;39(8):e 106-7.)
Read publication
Outpatient Closed-Loop Control With Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control
(Huyett et al. Diabetes Technol. Ther. 2017 Jun;19(6):331-339.)
Read publication
Randomized Controlled Trial of Mobile Closed-Loop Control
(Kovatchev et al. Diabetes Care 2020 Mar;43(3):607-615.)
Read publication
Brochures - Our Solutions
Highlights
Accu-Chek Care Platform
- All-in-one platform which enables integrated Personalised Diabetes Management (iPDM)
- Seamless connection with 150+ diabetes management devices and mySugr patient app, encouraging diabetes self-management
- Actionable insights for more efficient consultations
- The Customer Population Insights Dashboard provides population health analytics for HCPs, Admins, and Payers
- Patient tracking and therapy adjustment for personalised care
- Under constant evolution to support you now and in the future
View brochure
Accu-Chek Solo
- First detachable and tube-free insulin pump
- Unique quick bolus buttons on pump
- Diabetes Manager with open bolus advice to combine therapy with continuous glucose monitoring solutions
- Connected to the Accu-Chek Care platform, allowing the combined visualisation of insulin and blood glucose data to detect therapy patterns and improve outcomes
View brochure
Accu-Chek Guide
- Spill-resistant SmartPack vial:: Easy to take out one strip at a time
- Simple to see, day or night: Bright port light and backlit display
- Wide dosing area: Simply touch any part of the yellow edge to your blood drop.
Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure
Accu-Chek Guide Me
- Large, easy-to-read display
- Simple two-button navigation
- Fast, easy-to-fill strip with results in less than 4 seconds
Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure
Accu-Chek Instant
- Instant understanding: The target range indicator provides an instant view to see if your result is high, low, or in range
- Easy to read: Clearly see results on the large backlit display.
- Easy testing: Apply blood on the edge of the wide application area.
- Clean strip disposal: Simple ejector for hygienic removal
- Connects to mySugr app and Accu-Chek Care platform to enable integrated Personalised Diabetes Management (iPDM).
View brochure
mySugr app
- More than 5.5 million registered users
- Automated data integration of leading BG meters (e.g. Accu-Chek Guide), CGM and activity data from cloud-based integrations Apple health (Dexcom G5/G6) and Google Fit (steps)
- mySugr PRO includes a bolus calculator in certain countries.
- Comprehensive reports to share from the mySugr app with Healthcare Professionals
- Integrations:
- Accu-Chek Care Platform: Integration of BG values, carb information, CGM, and insulin data into Accu-Chek Care platform
- Smart insulin pen integration: Integration of insulin data from the NovoPen 6 and NovoPen Echo Plus into the mySugr Logbook
View brochure
More solution brochures
 - Kopie.png)
Smart Pen Integration in mySugr Logbook
- All-in-one: Manage glucose levels, insulin, and carb data in just one app.
- Easy: Automated logging of insulin time and dose together with glucose values
- Multiple pen pairing: Option to connect up to 8 pens
- Intuitive visualisation: Valuable insights on patterns and therapy effectiveness
View brochure
Visit us
We look forward to welcoming you to our booth and talk with you about our solutions for an integrated Personalised Diabetes Management!
For those who will join the ATTD conference online, please make sure to visit our virtual Showroom, where you find more information on integrated Personalised Diabetes Management. Feel free to contact us for more information and visit us on LinkedIn .